SL Science Holding Limited Ordinary Shares

SLBT · NASDAQ · Healthcare / Biotechnology

0.727USD-0.04 (-4.88%)

Price History

Full chart

Market Stats

Previous Close0.7643

Open0.7701

Day Range0.7001 – 0.7901

52-Week Range1.42 – 14.50

Volume25.23K

Market Cap880.39M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.01

Dividend Yield0.00%

50-Day Avg2.69

200-Day Avg7.27

About

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Ching-Dong Wang
Employees14
HeadquartersNo. 479, Chongyang Rd., Taipei, Taiwan, 115010, USA
Websitehttps://www.sl-bio.com

Leadership

Mr. Ching-Dong WangFounder, Chairman & CEO · b. 1972
Mr. Ray LeungCFO & Director · b. 1982
Dr. Ethan Shen Ph.D.CTO & Director · b. 1977

Financials

Income Statement

Currency: USD	2023-12-31	2024-12-31	2025-12-31
Total Revenue	878.97K	3.36M	2.20M
Growth (%)	-	+282.68%	-34.68%
Cost of Revenue	140.96K	1.43M	1.42M
Gross Profit	738.01K	1.93M	775.06K
Gross Margin	83.96%	57.46%	35.27%
Operating Expense	641.18K	3.13M	4.61M
Operating Income	96.83K	-1.20M	-3.84M
Operating Margin	11.02%	-35.56%	-174.65%
EBITDA	134.02K	-1.15M	-3.74M
EBITDA Margin	15.25%	-34.16%	-170.39%
Net Income	399.04K	-1.19M	-3.82M
Net Income Margin	45.40%	-35.42%	-173.85%
R&D	0	2.02M	2.07M
R&D as % of Total Revenue	0.00%	60.06%	94.16%

Balance Sheet

Currency: USD	2023-12-31	2024-12-31	2025-12-31
Total Assets	4.24M	5.93M	2.82M
Total Liabilities	668.07K	204.90K	533.28K
Total Equity	3.57M	5.73M	2.28M
Cash	276.85K	3.68M	1.26M
Total Debt	550.06K	-	213.41K
Net Debt	273.21K	-3.68M	-1.05M

Cash Flow

Currency: USD	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-2.45M	280.16K	-1.91M
Investing Cash Flow	-182.98K	123.28K	-319.69K
Financing Cash Flow	2.86M	3.07M	-879.14K
Capital Expenditure	182.98K	7.97K	319.69K
Free Cash Flow	-2.64M	272.19K	-2.23M
FCF to OCF	107.46%	97.16%	116.74%

Key Statistics & Ratios

Market Cap880.39M

Enterprise Value907.39M

Trailing P/E0.00

Forward P/E0.00

Price / Sales269.23

Price / Book397.75

EPS-0.01

Book Value1.29

Revenue (TTM)3.27M

Gross Profit (TTM)1.26M

EBITDA-2.28M

Profit Margin-72.46%

Operating Margin-142.55%

Return on Equity-25.62%

Return on Assets-14.70%

Shares Outstanding560.76M

Shares Float0

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Ownership Breakdown

Institutions: 0.29%
Insiders: 59.55%
Retail / Other: 40.16%

Top Institutional Holders

RiverNorth Capital Management, LLC
130.00K0.02%

Top Fund Holders

Fidelity Nasdaq Composite Index
338.21K0.06%